Clinical trial
Clinical Study and Mechanism Exploration of Acupuncture at Neiguan (PC6) for Preventing Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT07747194 is registered in ClinicalTrials.gov with Xiao Wang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study and Mechanism Exploration of Acupuncture at Neiguan (PC6) for Preventing Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Lead sponsor
- Xiao Wang
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- July 1, 2026
- Completion date
- December 30, 2027
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced nausea and vomiting (cinv), hematopoietic stem cell transplantation (hsct)